198 related articles for article (PubMed ID: 36891988)
1. Targeting regulatory T cell metabolism in disease: Novel therapeutic opportunities.
Halvorson T; Tuomela K; Levings MK
Eur J Immunol; 2023 Sep; 53(9):e2250002. PubMed ID: 36891988
[TBL] [Abstract][Full Text] [Related]
2. Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis.
Kumar P; Saini S; Prabhakar BS
Semin Cancer Biol; 2020 Aug; 64():29-35. PubMed ID: 30716481
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targeting of regulatory T cells in cancer.
Shan F; Somasundaram A; Bruno TC; Workman CJ; Vignali DAA
Trends Cancer; 2022 Nov; 8(11):944-961. PubMed ID: 35853825
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T Cells in Autoimmunity and Cancer: A Duplicitous Lifestyle.
Hatzioannou A; Boumpas A; Papadopoulou M; Papafragkos I; Varveri A; Alissafi T; Verginis P
Front Immunol; 2021; 12():731947. PubMed ID: 34539668
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T cell targeting in cancer: Emerging strategies in immunotherapy.
Dees S; Ganesan R; Singh S; Grewal IS
Eur J Immunol; 2021 Feb; 51(2):280-291. PubMed ID: 33302322
[TBL] [Abstract][Full Text] [Related]
6. Understanding and Targeting Human Cancer Regulatory T Cells to Improve Therapy.
Kolb HR; Borcherding N; Zhang W
Adv Exp Med Biol; 2021; 1278():229-256. PubMed ID: 33523451
[TBL] [Abstract][Full Text] [Related]
7. Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy.
Tay C; Tanaka A; Sakaguchi S
Cancer Cell; 2023 Mar; 41(3):450-465. PubMed ID: 36917950
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Pathways Involved in Regulatory T Cell Functionality.
Kempkes RWM; Joosten I; Koenen HJPM; He X
Front Immunol; 2019; 10():2839. PubMed ID: 31849995
[TBL] [Abstract][Full Text] [Related]
9. Garp as a therapeutic target for modulation of T regulatory cell function.
Shevach EM
Expert Opin Ther Targets; 2017 Feb; 21(2):191-200. PubMed ID: 28001437
[TBL] [Abstract][Full Text] [Related]
10. Augmented Expansion of Treg Cells From Healthy and Autoimmune Subjects
Reading JL; Roobrouck VD; Hull CM; Becker PD; Beyens J; Valentin-Torres A; Boardman D; Lamperti EN; Stubblefield S; Lombardi G; Deans R; Ting AE; Tree T
Front Immunol; 2021; 12():716606. PubMed ID: 34539651
[TBL] [Abstract][Full Text] [Related]
11. In or out of control: Modulating regulatory T cell homeostasis and function with immune checkpoint pathways.
Abdeladhim M; Karnell JL; Rieder SA
Front Immunol; 2022; 13():1033705. PubMed ID: 36591244
[TBL] [Abstract][Full Text] [Related]
12. Treg Enhancing Therapies to Treat Autoimmune Diseases.
Eggenhuizen PJ; Ng BH; Ooi JD
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977677
[TBL] [Abstract][Full Text] [Related]
13. Tumor resident regulatory T cells.
Glasner A; Plitas G
Semin Immunol; 2021 Feb; 52():101476. PubMed ID: 33906820
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Treg Cell Metabolism and Function in Non-Lymphoid Tissues.
Yang K
Front Immunol; 2022; 13():909705. PubMed ID: 35720275
[TBL] [Abstract][Full Text] [Related]
15. Anti-CD25 monoclonal antibody Fc variants differentially impact regulatory T cells and immune homeostasis.
Huss DJ; Pellerin AF; Collette BP; Kannan AK; Peng L; Datta A; Wipke BT; Fontenot JD
Immunology; 2016 Jul; 148(3):276-86. PubMed ID: 27012310
[TBL] [Abstract][Full Text] [Related]
16. Targeting of Cdc42 GTPase in regulatory T cells unleashes antitumor T-cell immunity.
Kalim KW; Yang JQ; Wunderlich M; Modur V; Nguyen P; Li Y; Wen T; Davis AK; Verma R; Lu QR; Jegga AG; Zheng Y; Guo F
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36427906
[TBL] [Abstract][Full Text] [Related]
17. Targeting regulatory T cells in tumors.
Liu C; Workman CJ; Vignali DA
FEBS J; 2016 Jul; 283(14):2731-48. PubMed ID: 26787424
[TBL] [Abstract][Full Text] [Related]
18. Regulatory T cell metabolism at the intersection between autoimmune diseases and cancer.
Kurniawan H; Soriano-Baguet L; Brenner D
Eur J Immunol; 2020 Nov; 50(11):1626-1642. PubMed ID: 33067808
[TBL] [Abstract][Full Text] [Related]
19. Targeting regulatory T cells in gastric cancer: Pathogenesis, immunotherapy, and prognosis.
Wang B; Zhang Z; Liu W; Tan B
Biomed Pharmacother; 2023 Feb; 158():114180. PubMed ID: 36586241
[TBL] [Abstract][Full Text] [Related]
20. Balancing cancer immunotherapy and immune-related adverse events: The emerging role of regulatory T cells.
Alissafi T; Hatzioannou A; Legaki AI; Varveri A; Verginis P
J Autoimmun; 2019 Nov; 104():102310. PubMed ID: 31421963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
